About This Program
Ozempic at Soboba
Ozempic (semaglutide) has become one of the most widely discussed weight loss medications in the world — and for good reason. As a GLP-1 receptor agonist, semaglutide works by mimicking glucagon-like peptide-1, a gut hormone that regulates appetite, slows stomach emptying, and signals satiety to the brain. The result is a clinically significant and sustained reduction in hunger that makes maintaining a caloric deficit far easier than willpower alone.\n\nIn the landmark STEP 1 clinical trial published in the New England Journal of Medicine, participants using semaglutide 2.4 mg alongside lifestyle intervention lost an average of 14.9% of their body weight over 68 weeks — compared to 2.4% in the placebo group. That's a meaningful, reproducible clinical result that has established physician-supervised semaglutide programs as one of the most effective non-surgical tools available in obesity medicine.\n\nAt Soboba Medical Weight Loss in Orange County, our physicians don't simply prescribe Ozempic and send patients home. Every Soboba patient on semaglutide has a structured follow-up schedule with regular physician check-ins, dose adjustments, and ongoing monitoring to ensure safety and optimize results. Our physicians evaluate you individually before starting — reviewing your full medical history, current medications, and weight loss goals — to determine whether Ozempic is appropriate and to build a program around it, not just a prescription.
How It Works
Your Soboba physician conducts a thorough initial evaluation — reviewing your medical history, existing conditions (including thyroid history, pancreatitis risk, and cardiovascular profile), and current medications — before confirming that Ozempic is appropriate for you.
Ozempic is introduced at a low starting dose (typically 0.25 mg weekly) and titrated gradually over several weeks to the therapeutic dose, minimizing common side effects like nausea and GI discomfort during the adjustment period.
As a GLP-1 receptor agonist, semaglutide activates receptors in the hypothalamus that regulate hunger signals — patients commonly report significantly reduced appetite, making it substantially easier to adhere to a reduced-calorie diet.
By slowing gastric emptying, Ozempic reduces post-meal blood sugar spikes and prolongs the sensation of fullness after eating — a dual mechanism that simultaneously supports weight loss and improved metabolic health.
Monthly physician check-ins allow for dose adjustments based on your progress and tolerance, as well as nutritional guidance, monitoring for any side effects, and assessment of overall health improvements.
Unlike obtaining a prescription without ongoing support, the Soboba Ozempic program includes physician visits at no additional charge — ensuring your treatment is properly managed from your first dose to your goal weight.
All Soboba Programs Include
Ready to Start?
Same-week appointments available. Call any of our 3 Orange County locations — first consultation is free.
Key Benefits
Start Your Ozempic Program Today
Ozempic is one of the most clinically proven weight loss tools available today — but its safety and effectiveness depend entirely on proper medical oversight, gradual dose titration, and ongoing support. Soboba's physicians have the experience to manage your program correctly. Call any of our three Orange County locations today — your first consultation is free and same-week appointments are available.
Call Now — Free ConsultationSame-week appointments available · No contracts · No startup fees
Individual results may vary. This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. All programs are supervised by licensed physicians. These statements have not been evaluated by the Food and Drug Administration.
What to Expect
Side Effects and Managing Tolerability
Most side effects from semaglutide occur during the titration period as your body adjusts to each dose increase. Soboba physicians start at the lowest effective dose and increase slowly — a schedule designed to keep side effects minimal while your body adapts. Most patients find that nausea and GI discomfort improve significantly within a few weeks of each new dose level.
Common Side Effects
Serious Risks (Rare)
Black box warning: Semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN 2), based on animal studies. Your Soboba physician will review your thyroid history at your initial evaluation before prescribing.
Common Questions
Frequently Asked Questions
Is Ozempic the same as Wegovy?
Both contain semaglutide, but they are not the same product. Ozempic (0.5–2 mg weekly) is FDA-approved for type 2 diabetes management. Wegovy (2.4 mg weekly) is FDA-approved specifically for chronic weight management in adults with obesity or overweight with a weight-related condition. Wegovy uses a higher dose optimized for weight loss outcomes — which is why the STEP 1 trial used the 2.4 mg dose.
How long until I see results?
Most patients notice reduced appetite within the first 2–4 weeks. Measurable weight loss typically begins in the first month and compounds as the dose is titrated upward. The STEP 1 clinical trial measured outcomes over 68 weeks, reflecting the cumulative benefit of sustained treatment at the full dose — significant results continue to build through months 3–6 and beyond.
What if Ozempic isn't producing enough results?
Some patients achieve partial results on semaglutide or eventually reach a plateau. In these cases, your Soboba physician may recommend switching to tirzepatide — the active ingredient in Mounjaro (FDA-approved for type 2 diabetes) and Zepbound (FDA-approved for chronic weight management). Tirzepatide activates an additional hormonal pathway (GIP) and has demonstrated stronger average weight loss in clinical trials — 20.9% vs. 14.9% for semaglutide. This is a common, evidence-supported transition.
Is compounded semaglutide available at Soboba?
Compounded semaglutide was previously available as an affordability alternative to brand-name Ozempic and Wegovy. FDA policy changes in 2025 removed semaglutide from the shortage-based compounding exemptions that had previously allowed broader access — availability is no longer routine. Please speak directly with your Soboba physician at your free consultation for the most current information on available medications and pricing.
Will I need to take Ozempic indefinitely?
Not necessarily. Some patients use semaglutide to achieve a goal weight and then transition to a maintenance approach. However, clinical data shows that weight typically returns after stopping GLP-1 medications without a complementary long-term strategy. Your Soboba physician will discuss your long-term options at your regular check-ins as you progress.
Explore Related Programs
Also Consider These Options
🏆
Mounjaro (Tirzepatide)
If you want stronger results or have plateaued on semaglutide, Mounjaro's dual GIP + GLP-1 mechanism averages 20.9% weight loss in SURMOUNT-1 — the most powerful medication in this class.
🧬
GLP-1 Injections Overview
Compare the full GLP-1 drug class — how semaglutide and tirzepatide differ, clinical trial data, side effects, and how Soboba determines which option fits your health profile.
🔬
GLP-3 Injections
Retatrutide — the next-generation triple-receptor agonist in Phase 3 trials. Learn about what's coming next in weight loss medicine.